scispace - formally typeset
C

Catherine Monnot

Researcher at PSL Research University

Publications -  49
Citations -  2672

Catherine Monnot is an academic researcher from PSL Research University. The author has contributed to research in topics: Angiotensin II & Angiogenesis. The author has an hindex of 24, co-authored 47 publications receiving 2386 citations. Previous affiliations of Catherine Monnot include Centre national de la recherche scientifique & Collège de France.

Papers
More filters
Journal ArticleDOI

Angiopoietin-Like 4 Is a Proangiogenic Factor Produced during Ischemia and in Conventional Renal Cell Carcinoma

TL;DR: ANGPTL4, originally identified as a peroxisome proliferator-activated receptor alpha and gamma target gene, has potential for use as a new diagnostic tool and a potential therapeutic target, modulating angiogenesis both in tumors and in ischemic tissues.
Journal ArticleDOI

Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness

TL;DR: Results show that ANGPTL4, through its action on both vascular and tumor compartments, prevents the metastatic process by inhibiting vascular activity as well as tumor cell motility and invasiveness.
Journal ArticleDOI

Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants.

TL;DR: In this paper, the roles of 7 amino acids of the rat AT1A receptor in ligand binding and signaling were investigated by performing functional assays of individual receptor mutants expressed in COS and Chinese hamster ovary cells.
Journal ArticleDOI

Extracellular Matrix–Bound Angiopoietin-Like 4 Inhibits Endothelial Cell Adhesion, Migration, and Sprouting and Alters Actin Cytoskeleton

TL;DR: It is observed in a mouse model of hindlimb ischemia that the mRNA upregulation in the vessels correlates with the accumulation of the full-length protein in ischemic tissues, which negatively regulates their angiogenic capacities through an autocrine pathway.